Related Experiment Video

Updated: Mar 2, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.3K

microRNA-200a-3p increases 5-fluorouracil resistance by regulating dual specificity phosphatase 6 expression

Heejin Lee1, Chongtae Kim1, Hoin Kang1

  • 1Department of Biochemistry, The Catholic University of Korea College of Medicine, Seoul, South Korea.

Experimental & Molecular Medicine
|May 13, 2017
PubMed

Insights

MicroRNAs (miRNAs) regulate anti-cancer drug resistance. miR-200a-3p enhances resistance to 5-fluorouracil and other chemotherapy drugs by targeting DUSP6, offering new therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Acquisition of anti-cancer drug resistance is a major challenge in cancer therapy.
  • Mechanisms underlying cancer drug resistance are not fully understood.

Purpose of the Study:

  • Investigate the role of microRNAs (miRNAs) in the development of resistance to 5-fluorouracil (5-FU).
  • Identify specific miRNAs that regulate anti-cancer drug resistance.

Main Methods:

  • Screened a lentivirus library of 572 precursor miRNAs in human hepatocellular carcinoma Hep3B cells.
  • Characterized miR-200a-3p expression and its effect on cell viability and growth.
  • Utilized miRNA mimics and inhibitors to modulate miR-200a-3p levels.
  • Identified and validated dual-specificity phosphatase 6 (DUSP6) as a target gene.

Main Results:

  • Five miRNAs were found to promote cell survival after 5-FU treatment.
  • Hep3B cells expressing miR-200a-3p exhibited increased resistance to 5-FU.
  • miR-200a-3p mimic enhanced, while inhibition downregulated, cell viability against 5-FU, doxorubicin, and cisplatin.
  • DUSP6 was identified as a direct target of miR-200a-3p, and its expression mitigated miR-200a-3p's pro-survival effects.

Conclusions:

  • miR-200a-3p plays a crucial role in acquiring resistance to multiple anti-cancer drugs.
  • The miR-200a-3p/DUSP6 axis is a novel mechanism contributing to anti-cancer drug resistance.
  • Targeting miR-200a-3p or modulating DUSP6 expression may represent potential therapeutic strategies for overcoming drug resistance.

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

3.7K

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
56
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
42